Bridger Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-916,314
Closed -$9.49M 31
2022
Q3
$9.49M Sell
916,314
-39,700
-4% -$411K 2.87% 14
2022
Q2
$11M Buy
956,014
+26,300
+3% +$303K 2.48% 18
2022
Q1
$11.7M Hold
929,714
1.92% 19
2021
Q4
$10.8M Sell
929,714
-40,800
-4% -$476K 1.4% 26
2021
Q3
$12.7M Sell
970,514
-1,064,600
-52% -$13.9M 1.48% 24
2021
Q2
$26.2M Sell
2,035,114
-817,300
-29% -$10.5M 2.44% 18
2021
Q1
$31.9M Buy
2,852,414
+385,442
+16% +$4.31M 2.98% 17
2020
Q4
$28.1M Sell
2,466,972
-308,495
-11% -$3.51M 2.14% 21
2020
Q3
$25M Buy
2,775,467
+852,434
+44% +$7.67M 2% 21
2020
Q2
$19.8M Buy
1,923,033
+378,443
+25% +$3.91M 1.84% 22
2020
Q1
$15.6M Buy
+1,544,590
New +$15.6M 1.8% 24
2019
Q2
Sell
-4,993,179
Closed -$56.6M 33
2019
Q1
$56.6M Hold
4,993,179
4.48% 8
2018
Q4
$43.3M Buy
4,993,179
+4,250,641
+572% +$36.9M 3.61% 12
2018
Q3
$11.5M Buy
+742,538
New +$11.5M 0.66% 33
2017
Q4
Sell
-3,040,037
Closed -$40.2M 34
2017
Q3
$40.2M Buy
3,040,037
+1,684,513
+124% +$22.2M 2.4% 21
2017
Q2
$21.4M Sell
1,355,524
-517,411
-28% -$8.18M 1.22% 33
2017
Q1
$26.8M Sell
1,872,935
-370,965
-17% -$5.3M 1.53% 32
2016
Q4
$28.7M Sell
2,243,900
-2,441,754
-52% -$31.3M 2% 23
2016
Q3
$62.3M Sell
4,685,654
-2,380,036
-34% -$31.7M 4.2% 8
2016
Q2
$77.4M Buy
7,065,690
+882,408
+14% +$9.66M 5% 5
2016
Q1
$56.7M Buy
6,183,282
+279,437
+5% +$2.56M 3.92% 8
2015
Q4
$57.3M Buy
5,903,845
+233,806
+4% +$2.27M 1.89% 11
2015
Q3
$49.5M Buy
5,670,039
+2,673,036
+89% +$23.3M 3.37% 13
2015
Q2
$30.3M Buy
2,997,003
+1,993,471
+199% +$20.1M 0.96% 28
2015
Q1
$13.4M Buy
+1,003,532
New +$13.4M 0.9% 33